Location: OnlineJoin the STERIS Life Sciences team for a wonderful learning opportunity during our upcoming webinar.
Juha Mattila, our STERIS technical expert, will explain the VHP LTS-V low temperature deep vacuum vaporized hydrogen peroxide (VHP) terminal sterilization process and theory.
Why attend the presentation:
With the growing production of drugs that are heat sensitive, pharmaceutical manufacturing facilities are under pressure to improve their material transfer bioburden and offer low-temperature sterilization methods that won’t alter the drug’s properties. STERIS Vaporized Hydrogen Peroxide low temperature sterilization technology (VHP LTS-V) offers a solution to low-temperature (+28…40 °C) surface sterilization needs for biologics, biosimilar, ophthalmic, combination drugs, implants and other applications where the drug components are sensitive to heat and or radiation. In addition, bringing materials to aseptic manufacturing areas can also become a bottleneck due to manual wiping of material bags and supplies going through an airlock to minimize bioburden and particles contamination. The STERIS VHP DC-A atmospheric pass-through decontamination chambers for material transfer provide a solution to these issues. This presentation will explain the VHP surface sterilization processes and theory, how to implement these processes to manufacturing, typical applications with examples, and will discuss product feasibility testing, cycle development, and validation procedures.
Who will benefit:
• Drug development & R&D Executives
• Manufacturing Managers
• Quality managers & Directors
• Delivery Device Designers
• Validation managers & Directors
Duration: 1 hour